FDA Approach To Third Drug Class Expected Within Months
Executive Summary
FDA will include industry in the process of developing a distribution channel for drugs between the traditional prescription and over-the-counter spaces, agency representatives said at the Consumer Healthcare Products Association's Regulatory and Scientific Conference